Safety and Efficacy Evaluation of Carnosine, an Endogenous Neuroprotective Agent for Ischemic Stroke
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background and Purpose—: An urgent need exists to develop therapies for stroke that have high efficacy, long therapeutic time windows, and acceptable toxicity. We undertook preclinical investigations of a novel therapeutic approach involving supplementation with carnosine, an endogenous pleiotropic dipeptide. Methods—: Efficacy and safety of carnosine treatment was evaluated in rat models of permanent or transient middle cerebral artery occlusion. Mechanistic studies used primary neuronal/astrocytic cultures and ex vivo brain homogenates. Results—: Intravenous treatment with carnosine exhibited robust cerebroprotection in a dose-dependent manner, with long clinically relevant therapeutic time windows of 6 hours and 9 hours in transient and permanent models, respectively. Histological outcomes and functional improvements including motor and sensory deficits were sustained on 14th day poststroke onset. In safety and tolerability assessments, carnosine did not exhibit any evidence of adverse effects or toxicity. Moreover, histological evaluation of organs, complete blood count, coagulation tests, and the serum chemistry did not reveal any abnormalities. In primary neuronal cell cultures and ex vivo brain homogenates, carnosine exhibited robust antiexcitotoxic, antioxidant, and mitochondria protecting activity. Conclusions—: In both permanent and transient ischemic models, carnosine treatment exhibited significant cerebroprotection against histological and functional damage, with wide therapeutic and clinically relevant time windows. Carnosine was well tolerated and exhibited no toxicity. Mechanistic data show that it influences multiple deleterious processes. Taken together, our data suggest that this endogenous pleiotropic dipeptide is a strong candidate for further development as a stroke treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352 · cited 2×
“Nevertheless, more thorough preclinical evaluation is needed for carnosine to meet the Stroke Therapeutic Academic Industry Roundtable guidelines and before clinical testing can take place.(16) In the present study, we determined: (1) short- and longterm neuroprotective efficacy of intravenous carnosine in rats using…”
Background
Cited by
Physiology and Pathophysiology of Carnosine
Boldyrev, A. A., Aldini, G., & Derave, W. (2013) · Physiological Reviews · doi:10.1152/physrev.00039.2012 · Cited by 1,114
Baek, S.-H., Noh, A. R., Kim, K.-A., Akram, M., Shin, Y.-J., Kim, E.-S., Yu, S. W., Majid, A., & Bae, O.-N. (2014) · Stroke · doi:10.1161/strokeaha.114.005183 · Cited by 174
“Processed brain homogenates or brain mitochondria were examined in Western blot using Tris-HCl SDS-PAGE.23,32 Detailed information on primary antibodies is described in the online-only Data Supplement.”
InfluentialSelf-citationSerum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia
Yang, Q., Zhao, J., Hao, J., Li, B., Huo, Y., Han, Y., Wan, L., Li, J., Huang, J., Lu, J., et al. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12246 · Cited by 170
“Previous studies showed that carnosine supplementation can regulate brain function in some patients and elevate plasma corticosterone concentrations via the hypothalamicpituitary-adrenal axis.(29) Recent research has demonstrated that carnosine has the potential to suppress the multiple biochemical changes of protein…”
BackgroundZhang, H.-T., Zhang, P., Gao, Y., Li, C.-L., Wang, H.-J., Chen, L.-C., Feng, Y., Li, R.-Y., Li, Y.-L., & Jiang, C.-L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5974 · Cited by 101
“Infarct size is widely used to determine the effectiveness of a drug for the treatment of ischemic stroke in most animal studies (20,21).”
Jing, Y., Bai, F., Wang, L., Yang, D., Yan, Y., Wang, Q., Zhu, Y., Yu, Y., & Chen, Z. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00177-22 · Cited by 37
“has been evaluated in rat models of permanent or transient middle cerebral artery occlusion (57).”
Background
Metadata
- Authors
- Bae, O.-N., Serfozo, K., Baek, S.-H., Lee, K. Y., Dorrance, A., Rumbeiha, W., Fitzgerald, S. D., Farooq, M. U., Naravelta, B., Bhatt, A., & Majid, A.
- Venue
- Stroke
- Published
- 2013-01
- Volume
- 44
- Issue
- 1
- Pages
- 205-212
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2137356761
- Cited by
- 91
- References
- 1
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.